Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $191M | $219M | $151M | $90.7M | $32.0M | $14.3M | $26.9M | $6.22M | $3.92M | $9.68M |
| Revenue growth | — | 14.9% | -31.1% | -40.0% | -64.7% | -55.4% | 88.6% | -76.9% | -36.9% | 146.7% |
| Operating income | -$125M | -$138M | -$506M | — | — | — | — | -$99.8M | -$135M | -$111M |
| Operating margin | -65.6% | -62.8% | -334.4% | — | — | — | — | -1602.5% | -3440.2% | -1141.1% |
| Net income | -$187M | -$117M | -$509M | -$322M | -$171M | -$92.2M | $28.3M | -$95.9M | -$126M | -$251M |
| Net margin | -97.7% | -53.3% | -336.9% | -355.3% | -533.0% | -646.0% | 105.2% | -1540.6% | -3216.2% | -2588.2% |
| EPS (diluted) | -$1.58 | -$0.98 | -$3.93 | -$2.09 | -$1.02 | -$0.47 | $0.14 | -$0.39 | -$0.47 | -$1.37 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$49.0M | -$104M | -$124M | -$136M | -$77.0M | -$55.8M | -$65.0M | -$66.9M | -$68.2M | -$87.8M |
| Capital expenditures | $31.6M | $46.7M | $41.6M | $37.9M | $7.53M | $7.25M | $4.92M | $1.54M | $8.58M | $2.00M |
| Free cash flow | -$80.6M | -$150M | -$166M | -$174M | -$84.5M | -$63.0M | -$70.0M | -$68.5M | -$76.8M | -$89.8M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $62.6M | $68.1M | $96.9M | $65.8M | $51.8M | $36.4M | $4.86M | $7.58M | $29.5M | $30.2M |
| Total assets | $949M | $847M | $716M | $456M | $315M | $360M | $216M | $151M | $145M | $156M |
| Total liabilities | $380M | $300M | $337M | $384M | $247M | $253M | $89.7M | $32.5M | $78.5M | $135M |
| Long-term debt | $7.56M | $7.54M | $211M | $186M | $172M | $180M | $0.00 | — | $0.00 | $93.2M |
| Shareholders' equity | $560M | $534M | $363M | $71.7M | $67.2M | $107M | $126M | $118M | $38.5M | $20.9M |
| Retained earnings | -$729M | -$848M | -$1.33B | -$1.65B | -$1.82B | -$1.92B | -$1.87B | -$1.96B | -$2.09B | -$2.34B |
| Shares (wtd avg diluted) | 119M | 122M | 160M | 154M | 167M | 198M | 200M | 245M | 268M | 313M |
Every figure is extracted from PRECIGEN, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.